1. Cardiovascular
and Metabolic Diseases, Innovative Medicines and Early Development
Biotech Unit, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden
2. AstraZeneca
MPI Satellite Unit, Department of Chemical Biology, Max Planck Institute of Molecular Physiology, Dortmund 44202, Germany